LGALS9 and colorectal cancer: These results suggest that TIM-3 and Gal-9 play opposing roles in colorectal cancer pathogenesis: TIM-3 may promote immune evasion and tumor progression, while Gal-9 may contribute to anti-tumor immunity [37].